This article is more than 5 years old. Information may no longer be current.
Cameron Turtle Receives Fred Hutch’s Endowed Chair for Immunotherapy
Click Here to Manage Email Alerts
Cameron Turtle, MD, PhD, a pioneer in the field of chimeric antigen receptor T-cell therapy, has been honored as the inaugural recipient of the Anderson Family Endowed Chair for Immunotherapy at Fred Hutchinson Cancer Research Center.
Turtle is a hematology oncologist with appointments as an attending physician in the Hematopoietic Cell Transplant Service and the Immunotherapy Service at Fred Hutch’s clinical-care partner, the Seattle Cancer Care Alliance, in addition to serving as associate professor in the division of medical oncology at University of Washington School of Medicine.
He also is an associate member of the clinical research division at Fred Hutchinson Cancer Research Center, with clinical expertise in cellular immunotherapy and hematopoietic stem cell transplantation. Turtle’s lab at Fred Hutch focuses on research for genetic engineering of T cells for adoptive immunotherapy of B-cell hematologic malignancies, CAR T-cell therapy for acute myeloid leukemia, and immune reconstitution after HSCT.
“My wife and I have proudly supported the Hutch for more than 20 years,” Ric Anderson, secretary of Fred Hutch’s board of trustees, said in a press release. Anderson, along with his wife, Kaylene, and their three children, presented Turtle with the chair during an event in August.
“Every year the science coming out of here amazes us. So do the people. Dr. Turtle is one of the young pioneers of immunotherapy, which has given so much hope to so many people, and we are proud to support his work,” Anderson added.
The endowed chair for immunotherapy aims to advance Turtle’s work on how T cells can be engineered to be used as treatments for hematologic malignancies, such as lymphoma and leukemia.
“The Anderson family has made a wonderful gift to Fred Hutch that will provide an extraordinary boost to cancer immunotherapy research and help new ideas move rapidly toward the patients who need them,” Turtle said in the press release.